Literature DB >> 22543907

The contribution of chronic kidney disease to the global burden of major noncommunicable diseases.

Keng-Thye Woo1, Hui L Choong2, Kok-Seng Wong2, Hwee Boon Tan2, Choong-Meng Chan2.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22543907     DOI： 10.1038/ki.2012.39

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  16 in total

1.  Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis.

Authors:  Nathan L Price; Verónica Miguel; Wen Ding; Abhishek K Singh; Shipra Malik; Noemi Rotllan; Anna Moshnikova; Jakub Toczek; Caroline Zeiss; Mehran M Sadeghi; Noemi Arias; Ángel Baldán; Oleg A Andreev; Diego Rodríguez-Puyol; Raman Bahal; Yana K Reshetnyak; Yajaira Suárez; Carlos Fernández-Hernando; Santiago Lamas
Journal:  JCI Insight       Date:  2019-11-14

2.  The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKD.

Authors:  Rakesh Malhotra; Ronit Katz; Andrew Hoofnagle; Andrew Bostom; Dena E Rifkin; Ruth Mcbride; Jeffrey Probstfield; Geoffrey Block; Joachim H Ix
Journal:  Clin J Am Soc Nephrol       Date:  2017-12-05       Impact factor: 8.237

3.  PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.

Authors:  Charles Ginsberg; Timothy E Craven; Michel B Chonchol; Alfred K Cheung; Mark J Sarnak; Walter T Ambrosius; Anthony A Killeen; Kalani L Raphael; Udayan Y Bhatt; Jing Chen; Glenn M Chertow; Barry I Freedman; Suzanne Oparil; Vasilios Papademetriou; Barry M Wall; Clinton B Wright; Joachim H Ix; Michael G Shlipak
Journal:  Clin J Am Soc Nephrol       Date:  2018-11-13       Impact factor: 8.237

Review 4.  Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysis.

Authors:  Rakesh Malhotra; Hoang Anh Nguyen; Oscar Benavente; Mihriye Mete; Barbara V Howard; Jonathan Mant; Michelle C Odden; Carmen A Peralta; Alfred K Cheung; Girish N Nadkarni; Ruth L Coleman; Rury R Holman; Alberto Zanchetti; Ruth Peters; Nigel Beckett; Jan A Staessen; Joachim H Ix
Journal:  JAMA Intern Med       Date:  2017-10-01       Impact factor: 21.873

5.  Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.

Authors:  Christiane Drechsler; Salim S Hayek; Changli Wei; Sanja Sever; Bernd Genser; Vera Krane; Andreas Meinitzer; Winfried März; Christoph Wanner; Jochen Reiser
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-11       Impact factor: 8.237

6.  Serum levels of WNT1-inducible signaling pathway protein-1 (WISP-1): a noninvasive biomarker of renal fibrosis in subjects with chronic kidney disease.

Authors:  Xiang Zhong; Yue Ju Tu; Yi Li; Ping Zhang; Wei Wang; Sha Sha Chen; Li Li; Arthur Ck Chung; Hui Yao Lan; Hai Yong Chen; Gui Sen Li; Li Wang
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

7.  Angiotensin II Type 1 Receptor-Associated Protein Regulates Kidney Aging and Lifespan Independent of Angiotensin.

Authors:  Kazushi Uneda; Hiromichi Wakui; Akinobu Maeda; Kengo Azushima; Ryu Kobayashi; Sona Haku; Kohji Ohki; Kotaro Haruhara; Sho Kinguchi; Miyuki Matsuda; Masato Ohsawa; Shintaro Minegishi; Tomoaki Ishigami; Yoshiyuki Toya; Yoshitoshi Atobe; Akio Yamashita; Satoshi Umemura; Kouichi Tamura
Journal:  J Am Heart Assoc       Date:  2017-07-27       Impact factor: 5.501

8.  Association between Dietary Mineral Intake and Chronic Kidney Disease: The Health Examinees (HEXA) Study.

Authors:  Jeewoo Kim; Juyeon Lee; Kyoung-Nam Kim; Kook-Hwan Oh; Curie Ahn; Jongkoo Lee; Daehee Kang; Sue K Park
Journal:  Int J Environ Res Public Health       Date:  2018-05-24       Impact factor: 3.390

9.  Efficacy and safety of febuxostat for treating hyperuricemia in patients with chronic kidney disease and in renal transplant recipients: A systematic review and meta-analysis.

Authors:  Xuzhong Liu; Kun Liu; Qing Sun; Yunyan Wang; Junsong Meng; Zongyuan Xu; Zhaofei Shi
Journal:  Exp Ther Med       Date:  2018-06-28       Impact factor: 2.447

10.  Annual all-cause mortality rate for patients with diabetic kidney disease in Singapore.

Authors:  Yee Gary Ang; Bee Hoon Heng; Nakul Saxena; Seng Teck Adrian Liew; Phui-Nah Chong
Journal:  J Clin Transl Endocrinol       Date:  2016-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.